Combined Cerebrolysin and Amantadine Sulfate Administration for Patients With Traumatic Brain Injury in the ICU
Key facts
- Who runs it
- Ain Shams University
- Where
- Egypt1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- Phase
- Phase 3
- People taking part
- 150 people enrolled
- Started
- 1 Sept 2023
- Ended
- 1 Aug 2025
- Type of study
- Interventional, 3 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- Cerebrolysin
- amantadine sulfate
- Record updated
- 19 November 2025
Who can take part
- Age
- 18 years to 70 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 9 criteriaShow less
Who can take part
- Age between 18 and 70 years
- Clinical diagnosis of head injury with moderate to severe TBI and a Glasgow coma scale (GCS) score of 7-12 at the time of hospital admission
- Pre-hospital intubation/sedation/paralysis was accepted if the GCS score had been assessed before intubation/sedation/paralysis by trained staff
Who cannot take part
- History of intracranial interventions as well as ischemic or hemorrhagic stroke
- Any neurological or non-neurological condition independent from TBI that might influence the functional outcome or other efficacy outcome measures
- Patient with sever renal impairment (creatinine clearance > 30 ml/ minute)
- Clear clinical signs of intoxication influencing the evaluation, in the investigator's judgment
- Patients with penetrating brain injury
- Pregnancy or lactation
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The goal of this interventional study is to Measure the potential benefits of combined administration of cerebrolysin and amantadine sulfate as an add-on therapy to the standard management of patients admitted to the ICU with traumatic brain injury.
The 3 groups in the trial
- standard of careNo study treatment, for comparison
patients receiving the standard protocol of management of head injury in the ICU including * Ventilatory support, sedation and analgesia. * Hemodynamic support. * Hyperosmolar therapy. * Early post traumatic seizure prophylaxis. * Nutritional support: will try to start enteral feeds as soon as possible or total parenteral * nutrition will be used in the case of enteral feeding intolerance. * Temperature management: to maintain normothermia * Glycemic control: to maintain a glucose level of \[140 -180 mg/dl\] * Peptic ulcer prophylaxis: * Deep venous thrombosis (DVT) prophylaxis
- standard of care + CerebrolysinTreatment being tested
patients receiving the standard protocol of management of head injury in the ICU plus 2 cycles of Cerebrolysin , each cycle 10 days, for total 20 days. From day 1 to day 10: cerebrolysin 50 ml once daily diluted in 250 ml normal saline intravenous infusion over 15 minutes. From day 21-30 : cerebrolysin 20 ml once daily diluted in 250 ml normal saline intravenous infusion over 15 minutes.
Treatment: Cerebrolysin
- standard of care + Cerebrolysin + Amantadine sulfateTreatment being tested
patients receiving the standard protocol of management of head injury in the ICU plus amantadine sulfate at a dose of 100 mg twice daily on the day after randomization, with this dose will be continued for 14 days. The dose will be increased to 150 mg twice daily at week 3 and to 200 mg twice daily at week 4 (total 4 weeks), combined with 2 cycles of Cerebrolysin , each cycle 10 days, for total 20 days. From day 1 to day 10: cerebrolysin 50 ml once daily diluted in 250 ml normal saline intravenous infusion over 15 minutes. From day 21-30 : cerebrolysin 20 ml once daily diluted in 250 ml normal saline intravenous infusion over 15 minutes.
Treatment: Cerebrolysin and amantadine sulfate
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- The Impact and Outcomes of Combined Cerebrolysin and Amantadine Sulfate Administration on Management of Patients With Traumatic Brain Injury in the ICU
- Record updated
- 19 November 2025